BIOTECHNOLOGY VALUE FUND II LP
Insider CIK 1102444 · ARQL · RIGL · CYTK · ARRY · INFI 10% owner · TRGT · FPRX · GLYC · IMUX Director · RGDO · CCXI · CNCE · SNDX · NVUS · ONTY 10% owner · IMDZ · CALA · CTMX · PRNB · ALLK · XENE · PIRS · NVLS · EPIX · FDMT · MRUS · IDYA · RAIN Director · OLMA Director · CGEM · RPTX 10% owner · PNT · KYMR Director · MLTX Director, 10% owner · GPCR · THRD · XOMA Director, 10% owner · LGND · CAPS · CTIC Director · PTN · NBIX
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMUX IMMUNIC, INC. | A Award deriv | 2026-09-16 | 2026-09-18 | 25,370 | — | $0 | 25,370 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2026-09-16 | 2026-09-18 | 25,370 | — | $0 | 25,370 | SEC↗ |
| XOMA XOMA Royalty Corp | U Tender | 2026-07-14 | 2026-07-16 | 772,000 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | U Tender | 2026-07-14 | 2026-07-16 | 3,635,758 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | U Tender | 2026-07-14 | 2026-07-16 | 2,773,545 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | U Tender | 2026-07-14 | 2026-07-16 | 412,000 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 627,597 | $106.50 | $66.84M | 1,592,261 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 113,289 | $106.50 | $12.07M | 240,123 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 51,858 | $106.50 | $5.52M | 78,787 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-26 | 2026-06-26 | 837,914 | $106.50 | $89.24M | 1,960,881 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-06-18 | 2026-06-23 | 29,500 | — | $0 | 29,500 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2026-06-17 | 2026-06-22 | 22,195 | — | $0 | 22,195 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion deriv | 2026-05-14 | 2026-05-18 | 412 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion deriv | 2026-05-14 | 2026-05-18 | 2,313 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion deriv | 2026-05-14 | 2026-05-18 | 1,506 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion deriv | 2026-05-14 | 2026-05-18 | 772 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion | 2026-05-14 | 2026-05-18 | 772,000 | $4.03 | $3.11M | 772,000 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion | 2026-05-14 | 2026-05-18 | 412,000 | $4.03 | $1.66M | 412,000 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion | 2026-05-14 | 2026-05-18 | 1,506,000 | $4.03 | $6.07M | 2,773,545 | SEC↗ |
| XOMA XOMA Royalty Corp | C Conversion | 2026-05-14 | 2026-05-18 | 2,313,000 | $4.03 | $9.32M | 3,635,758 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-03-31 | 2026-04-02 | 248,530 | $16.79 | $4.17M | 1,039,238 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-03-31 | 2026-04-02 | 1,569,116 | $16.79 | $26.35M | 6,599,722 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2026-03-31 | 2026-04-02 | 1,932,354 | $16.79 | $32.44M | 8,302,735 | SEC↗ |
| RPTX Repare Therapeutics Inc. | U Tender | 2026-01-28 | 2026-01-30 | 548,938 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | U Tender | 2026-01-28 | 2026-01-30 | 5,309,432 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | U Tender | 2026-01-28 | 2026-01-30 | 4,308,573 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | U Tender | 2025-10-09 | 2025-10-14 | 4,726,743 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | U Tender | 2025-10-09 | 2025-10-14 | 560,797 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | U Tender | 2025-10-09 | 2025-10-14 | 6,194,145 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | X Exercise deriv | 2025-08-05 | 2025-08-07 | 1,481,634 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | X Exercise deriv | 2025-08-05 | 2025-08-07 | 1,235,030 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | X Exercise deriv | 2025-08-05 | 2025-08-07 | 203,336 | — | $0 | 0 | SEC↗ |
| EPIX ESSA Pharma Inc. | X Exercise | 2025-08-05 | 2025-08-07 | 203,336 | — | $0 | 560,808 | SEC↗ |
| EPIX ESSA Pharma Inc. | X Exercise | 2025-08-05 | 2025-08-07 | 1,235,030 | — | $0 | 4,726,809 | SEC↗ |
| EPIX ESSA Pharma Inc. | X Exercise | 2025-08-05 | 2025-08-07 | 1,481,634 | — | $0 | 6,194,224 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2025-08-05 | 2025-08-07 | 66 | $1.88 | $124 | 4,726,743 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2025-08-05 | 2025-08-07 | 11 | $1.88 | $21 | 560,797 | SEC↗ |
| EPIX ESSA Pharma Inc. | S Sale | 2025-08-05 | 2025-08-07 | 79 | $1.88 | $149 | 6,194,145 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2025-06-30 | 2025-07-01 | 142,604 | $44.00 | $6.27M | 2,798,795 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2025-06-30 | 2025-07-01 | 115,783 | $44.00 | $5.09M | 2,219,858 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2025-06-30 | 2025-07-01 | 58,780 | $44.00 | $2.59M | 353,412 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-07-01 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CBIO GLYCOMIMETICS INC | J Other deriv | 2025-06-13 | 2025-06-17 | 304,098 | — | $0 | 304,098 | SEC↗ |
| CBIO GLYCOMIMETICS INC | J Other deriv | 2025-06-13 | 2025-06-17 | 257,515 | — | $0 | 257,515 | SEC↗ |
| CBIO GLYCOMIMETICS INC | J Other deriv | 2025-06-13 | 2025-06-17 | 25,944 | — | $0 | 25,944 | SEC↗ |
| CBIO GLYCOMIMETICS INC | J Other | 2025-06-13 | 2025-06-17 | 657,308 | — | $0 | 707,116 | SEC↗ |
| CBIO GLYCOMIMETICS INC | J Other | 2025-06-13 | 2025-06-17 | 556,617 | — | $0 | 593,740 | SEC↗ |
| CBIO GLYCOMIMETICS INC | J Other | 2025-06-13 | 2025-06-17 | 56,079 | — | $0 | 62,383 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-06-11 | 2025-06-13 | 24,150 | — | $0 | 24,150 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2025-06-05 | 2025-06-09 | 6,682 | — | $0 | 6,682 | SEC↗ |
| XOMA XOMA Royalty Corp | S Sale | 2025-05-16 | 2025-05-20 | 265,316 | $27.10 | $7.19M | 1,267,545 | SEC↗ |
| XOMA XOMA Royalty Corp | S Sale | 2025-05-16 | 2025-05-20 | 127,407 | $27.10 | $3.45M | 1,322,758 | SEC↗ |
| ALLK Allakos Inc. | D To issuer | 2025-05-15 | 2025-05-19 | 6,777,935 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer | 2025-05-15 | 2025-05-19 | 8,679,726 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | D To issuer | 2025-05-15 | 2025-05-19 | 855,211 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | S Sale | 2025-01-24 | 2025-01-28 | 339,679 | $26.10 | $8.87M | 1,450,165 | SEC↗ |
| XOMA XOMA Royalty Corp | S Sale | 2025-01-24 | 2025-01-28 | 149,975 | $26.10 | $3.91M | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | S Sale | 2025-01-24 | 2025-01-28 | 85,776 | $26.10 | $2.24M | 1,532,861 | SEC↗ |
| XOMA XOMA Royalty Corp | S Sale | 2025-01-24 | 2025-01-28 | 75,287 | $26.10 | $1.96M | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-01-10 | 2025-01-14 | 22,740 | — | $0 | 336,288 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-01-10 | 2025-01-14 | 235,450 | — | $0 | 3,291,004 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2025-01-10 | 2025-01-14 | 161,810 | — | $0 | 2,627,590 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | D To issuer | 2025-01-10 | 2025-01-14 | 22,740 | — | $0 | 347,970 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | D To issuer | 2025-01-10 | 2025-01-14 | 235,450 | — | $0 | 2,655,977 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | D To issuer | 2025-01-10 | 2025-01-14 | 161,810 | — | $0 | 2,003,966 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | J Other | 2024-12-13 | 2024-12-17 | 174,958 | — | $0 | 282,223 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | J Other | 2024-12-13 | 2024-12-17 | 29,648 | — | $0 | 38,961 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | J Other | 2024-12-13 | 2024-12-17 | 234,323 | — | $0 | 371,916 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-12-04 | 2024-12-04 | 1,797,527 | — | $0 | 1,797,527 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-12-04 | 2024-12-04 | 153,441 | — | $0 | 153,441 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-12-04 | 2024-12-04 | 1,258,027 | $9.08 | $11.42M | 3,055,554 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-12-04 | 2024-12-04 | 1,047,044 | $9.08 | $9.51M | 2,465,780 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-12-04 | 2024-12-04 | 160,107 | $9.08 | $1.45M | 313,548 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-12-04 | 2024-12-04 | 1,418,736 | — | $0 | 1,418,736 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | D To issuer | 2024-12-04 | 2024-12-04 | 153,441 | — | $0 | 370,710 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | D To issuer | 2024-12-04 | 2024-12-04 | 1,797,527 | — | $0 | 2,891,427 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | D To issuer | 2024-12-04 | 2024-12-04 | 1,418,736 | — | $0 | 2,165,776 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | J Other deriv | 2024-11-08 | 2024-11-13 | 240,000 | — | $0 | 240,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | J Other deriv | 2024-11-08 | 2024-11-13 | 3,062,000 | — | $0 | 3,062,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | J Other deriv | 2024-11-08 | 2024-11-13 | 2,378,000 | — | $0 | 2,378,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | J Other | 2024-11-08 | 2024-11-13 | 2,378,000 | — | $0 | 662,970 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | J Other | 2024-11-08 | 2024-11-13 | 240,000 | — | $0 | 87,911 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | J Other | 2024-11-08 | 2024-11-13 | 3,062,000 | — | $0 | 830,237 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2024-10-29 | 2024-10-31 | 440,489 | $3.65 | $1.61M | 838,507 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2024-10-29 | 2024-10-31 | 2,100,244 | $3.65 | $7.67M | 6,235,545 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2024-10-29 | 2024-10-31 | 2,213,816 | $3.65 | $8.08M | 7,415,596 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | S Sale | 2024-10-29 | 2024-10-31 | 396,963 | $14.30 | $5.68M | 1,367,257 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | S Sale | 2024-10-29 | 2024-10-31 | 538,420 | $14.30 | $7.70M | 1,794,218 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | S Sale | 2024-10-29 | 2024-10-31 | 64,617 | $14.30 | $924.0K | 176,692 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-10-04 | 2024-10-08 | 1,030,589 | $50.00 | $51.53M | 10,235,089 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-10-04 | 2024-10-08 | 132,549 | $50.00 | $6.63M | 1,287,768 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2024-10-04 | 2024-10-08 | 836,862 | $50.00 | $41.84M | 8,168,838 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy deriv | 2024-08-20 | 2024-08-22 | 156,742 | $40.75 | $6.39M | 156,742 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy deriv | 2024-08-20 | 2024-08-22 | 201,546 | $40.75 | $8.21M | 201,546 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-28 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,000 | — | $0 | 23,000 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2024-06-06 | 2024-06-10 | 7,688 | — | $0 | 7,688 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2024-05-09 | 2024-05-13 | 2,526,238 | — | $0 | 2,526,238 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2024-05-09 | 2024-05-13 | 3,173,135 | — | $0 | 3,173,135 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2024-05-09 | 2024-05-13 | 232,068 | — | $0 | 232,068 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2024-05-09 | 2024-05-13 | 75,431 | — | $0 | 220,460 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2024-05-09 | 2024-05-13 | 821,121 | — | $0 | 2,633,679 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2024-05-09 | 2024-05-13 | 1,031,385 | — | $0 | 3,361,803 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-29 | 20,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-29 | 35,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-25 | 2024-01-29 | 185,388 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-25 | 2024-01-29 | 341,547 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-25 | 2024-01-29 | 1,734,960 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-25 | 2024-01-29 | 2,076,085 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-25 | 2024-01-29 | 2,870,985 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-25 | 2024-01-29 | 1,367,838 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy deriv | 2024-01-05 | 2024-01-09 | 550,425 | $25.25 | $13.90M | 550,425 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy deriv | 2024-01-05 | 2024-01-09 | 52,733 | $25.25 | $1.33M | 52,733 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy deriv | 2024-01-05 | 2024-01-09 | 375,856 | $25.25 | $9.49M | 375,856 | SEC↗ |
| PNT POINT Biopharma Global Inc | S Sale | 2023-12-18 | 2023-12-20 | 8,974,245 | $12.45 | $111.73M | 0 | SEC↗ |
| PNT POINT Biopharma Global Inc | S Sale | 2023-12-18 | 2023-12-20 | 7,290,667 | $12.45 | $90.77M | 0 | SEC↗ |
| PNT POINT Biopharma Global Inc | S Sale | 2023-12-18 | 2023-12-20 | 896,366 | $12.45 | $11.16M | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-16 | 2023-11-17 | 153,693 | $5.38 | $826.9K | 5,309,432 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-16 | 2023-11-17 | 125,909 | $5.38 | $677.4K | 4,308,573 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-16 | 2023-11-17 | 16,143 | $5.38 | $86.8K | 548,938 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-15 | 2023-11-17 | 47,712 | $5.00 | $238.6K | 532,795 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-15 | 2023-11-17 | 493,337 | $5.00 | $2.47M | 5,155,739 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-15 | 2023-11-17 | 390,507 | $5.00 | $1.95M | 4,182,664 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 83,708 | $14.07 | $1.18M | 2,104,075 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 103,885 | $14.07 | $1.46M | 2,656,191 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-06 | 10,106 | $14.07 | $142.2K | 294,632 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-02 | 2023-11-03 | 218,979 | $3.60 | $788.3K | 4,662,402 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-02 | 2023-11-03 | 72,479 | $3.60 | $260.9K | 485,083 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2023-11-02 | 2023-11-03 | 492,251 | $3.60 | $1.77M | 3,792,157 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-11-02 | 2023-11-06 | 26,772 | $11.64 | $311.6K | 284,526 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-11-02 | 2023-11-06 | 132,016 | $11.64 | $1.54M | 2,020,367 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-11-02 | 2023-11-06 | 57,618 | $11.64 | $670.7K | 2,552,306 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | J Other | 2023-09-14 | 2023-09-14 | 99,556 | — | $0 | 99,556 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-09-12 | 2023-09-14 | 677,853 | $9.84 | $6.67M | 3,584,512 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-09-12 | 2023-09-14 | 52,801 | $9.84 | $519.6K | 524,151 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2023-09-12 | 2023-09-14 | 775,278 | $9.84 | $7.63M | 4,688,954 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-28 | 60,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-28 | 120,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 239 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 344 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 12 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 191 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 1,250 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 1,594 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-28 | 50,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-28 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-28 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-28 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender deriv | 2023-06-26 | 2023-06-28 | 17 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-28 | 702,505 | $9.10 | $6.39M | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-28 | 1,526,147 | $9.10 | $13.89M | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-28 | 43,139 | $9.10 | $392.6K | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-28 | 2,595,239 | $9.10 | $23.62M | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-28 | 3,989,130 | $9.10 | $36.30M | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 21,520 | — | $0 | 21,520 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | A Award deriv | 2023-06-08 | 2023-06-12 | 11,297 | — | $0 | 11,297 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 10,967 | — | $0 | 10,967 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other deriv | 2023-05-10 | 2023-05-12 | 4,018,253 | — | $0 | 4,018,253 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other deriv | 2023-05-10 | 2023-05-12 | 2,929,660 | — | $0 | 2,929,660 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other deriv | 2023-05-10 | 2023-05-12 | 462,605 | — | $0 | 462,605 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other | 2023-05-10 | 2023-05-12 | 2,929,660 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other | 2023-05-10 | 2023-05-12 | 4,018,253 | — | $0 | 0 | SEC↗ |
| GPCR Structure Therapeutics Inc | J Other | 2023-05-10 | 2023-05-12 | 462,605 | — | $0 | 0 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2023-05-05 | 2023-05-09 | 3,084,090 | — | $0 | 3,084,090 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2023-05-05 | 2023-05-09 | 165,950 | — | $0 | 165,950 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2023-05-05 | 2023-05-09 | 2,028,645 | — | $0 | 2,028,645 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2023-05-05 | 2023-05-09 | 1,609,063 | — | $0 | 1,609,063 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2023-05-05 | 2023-05-09 | 2,446,209 | — | $0 | 2,446,209 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy deriv | 2023-05-05 | 2023-05-09 | 252,291 | — | $0 | 252,291 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2023-05-05 | 2023-05-09 | 1,055,445 | — | $0 | 2,330,418 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2023-05-05 | 2023-05-09 | 86,341 | — | $0 | 145,029 | SEC↗ |
| ELDN Eledon Pharmaceuticals, In | P Buy | 2023-05-05 | 2023-05-09 | 837,146 | — | $0 | 1,812,558 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2023-04-05 | 2023-04-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other deriv | 2023-01-19 | 2023-01-19 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other deriv | 2023-01-19 | 2023-01-19 | 260,000 | — | $0 | 260,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other deriv | 2023-01-19 | 2023-01-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other | 2023-01-19 | 2023-01-19 | 3,500,000 | — | $0 | 558,854 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other | 2023-01-19 | 2023-01-19 | 2,600,000 | — | $0 | 392,808 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | J Other | 2023-01-19 | 2023-01-19 | 300,000 | — | $0 | 64,161 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-01-12 | 2023-01-13 | 2,985 | $31.24 | $93.3K | 2,494,688 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-01-12 | 2023-01-13 | 15,912 | $31.24 | $497.1K | 1,888,351 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-01-11 | 2023-01-13 | 11,149 | $29.89 | $333.2K | 1,872,439 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2023-01-11 | 2023-01-13 | 10,961 | $29.89 | $327.6K | 2,491,703 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2023-01-06 | 2023-01-09 | 1,676 | $21.98 | $36.8K | 1,789,844 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2023-01-06 | 2023-01-09 | 1,573 | $21.98 | $34.6K | 1,618,637 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2023-01-05 | 2023-01-09 | 3,330 | $18.39 | $61.2K | 1,788,168 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2023-01-05 | 2023-01-09 | 15,670 | $18.39 | $288.2K | 1,617,064 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-12-20 | 2022-12-22 | 116,635 | $4.11 | $479.4K | 2,332,638 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-12-20 | 2022-12-22 | 87,831 | $4.11 | $361.0K | 1,764,220 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-12-20 | 2022-12-22 | 9,597 | $4.11 | $39.4K | 241,309 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-08 | 2022-11-10 | 970,171 | $5.83 | $5.66M | 2,870,985 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-08 | 2022-11-10 | 54,857 | $5.83 | $319.8K | 341,547 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-08 | 2022-11-10 | 685,330 | $5.83 | $4.00M | 2,076,085 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-27 | 2022-09-27 | 678 | $16.89 | $11.5K | 1,601,394 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-27 | 2022-09-27 | 1,004 | $16.89 | $17.0K | 1,784,838 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-26 | 2022-09-27 | 3,339 | $16.83 | $56.2K | 1,783,834 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-26 | 2022-09-27 | 3,021 | $16.83 | $50.8K | 1,600,716 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-23 | 2022-09-27 | 6,715 | $16.50 | $110.8K | 1,780,495 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-23 | 2022-09-27 | 9,885 | $16.50 | $163.1K | 1,597,695 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-16 | 2022-09-16 | 10,897 | $17.89 | $194.9K | 1,587,810 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-16 | 2022-09-16 | 13,396 | $17.89 | $239.7K | 1,773,780 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-15 | 2022-09-16 | 5,575 | $17.96 | $100.1K | 1,576,913 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2022-09-14 | 2022-09-16 | 26,441 | $17.25 | $456.1K | 1,571,338 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-08-22 | 2022-08-23 | 233,362 | $26.00 | $6.07M | 1,861,290 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-08-22 | 2022-08-23 | 27,117 | $26.00 | $705.0K | 257,754 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-08-22 | 2022-08-23 | 285,046 | $26.00 | $7.41M | 2,480,742 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion deriv | 2022-08-09 | 2022-08-11 | 5,631 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion deriv | 2022-08-09 | 2022-08-11 | 3,640 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion deriv | 2022-08-09 | 2022-08-11 | 1,024 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion deriv | 2022-08-09 | 2022-08-11 | 2,280 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion | 2022-08-09 | 2022-08-11 | 3,754,000 | — | $0 | 3,989,130 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion | 2022-08-09 | 2022-08-11 | 2,426,666 | — | $0 | 2,595,239 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-08-09 | 2022-08-11 | 469,040 | $6.12 | $2.87M | 19,839 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion | 2022-08-09 | 2022-08-11 | 682,666 | — | $0 | 702,505 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-08-09 | 2022-08-11 | 1,289,434 | $6.12 | $7.89M | 6,148 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | C Conversion | 2022-08-09 | 2022-08-11 | 1,519,999 | — | $0 | 1,526,147 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-08-09 | 2022-08-11 | 2,890,723 | $6.12 | $17.69M | 168,573 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | S Sale | 2022-08-09 | 2022-08-11 | 3,850,803 | $6.12 | $23.57M | 235,130 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-13 | 2022-06-15 | 68,327 | $12.73 | $869.8K | 3,299,906 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-13 | 2022-06-15 | 74,666 | $12.73 | $950.5K | 4,443,423 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-13 | 2022-06-15 | 6,168 | $12.73 | $78.5K | 412,604 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2022-06-10 | 2022-06-14 | 41,417 | $4.03 | $166.9K | 2,906,659 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2022-06-10 | 2022-06-14 | 158,583 | $4.03 | $639.1K | 3,913,676 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-06 | 2022-06-06 | 3,040 | $13.21 | $40.2K | 3,231,579 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-06 | 2022-06-06 | 20 | $13.21 | $264 | 406,436 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-06 | 2022-06-06 | 3,809 | $13.21 | $50.3K | 4,368,757 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-03 | 2022-06-06 | 258,797 | $12.29 | $3.18M | 3,228,539 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-03 | 2022-06-06 | 353,344 | $12.29 | $4.34M | 4,364,948 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-03 | 2022-06-06 | 31,903 | $12.29 | $392.1K | 406,416 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-02 | 2022-06-06 | 464,235 | $11.68 | $5.42M | 2,969,742 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-02 | 2022-06-06 | 660,654 | $11.68 | $7.72M | 4,011,604 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-06-02 | 2022-06-06 | 61,156 | $11.68 | $714.3K | 374,513 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-06-01 | 2022-06-03 | 405,641 | $11.00 | $4.46M | 4,058,854 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-06-01 | 2022-06-03 | 301,009 | $11.00 | $3.31M | 2,992,808 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-06-01 | 2022-06-03 | 44,746 | $11.00 | $492.2K | 364,161 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-27 | 2022-05-31 | 26,353 | $14.78 | $389.5K | 1,627,928 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-27 | 2022-05-31 | 3,223 | $14.78 | $47.6K | 230,637 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-27 | 2022-05-31 | 35,793 | $14.78 | $529.0K | 2,195,696 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-26 | 2022-05-31 | 90,372 | $14.21 | $1.28M | 1,601,575 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-26 | 2022-05-31 | 10,642 | $14.21 | $151.2K | 227,414 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-26 | 2022-05-31 | 123,043 | $14.21 | $1.75M | 2,159,903 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-20 | 2022-05-24 | 5,883 | $14.00 | $82.4K | 2,036,860 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-20 | 2022-05-24 | 37 | $14.00 | $518 | 216,772 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-20 | 2022-05-24 | 4,180 | $14.00 | $58.5K | 1,511,203 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2022-05-18 | 2022-05-20 | 8,996 | — | $0 | 8,996 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-05-18 | 2022-05-20 | 189,882 | $8.50 | $1.61M | 2,505,507 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-05-18 | 2022-05-20 | 5,730 | $8.50 | $48.7K | 313,357 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-05-18 | 2022-05-20 | 224,388 | $8.50 | $1.91M | 3,350,950 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-05-13 | 2022-05-16 | 53,598 | $9.14 | $489.9K | 3,653,213 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-05-13 | 2022-05-16 | 38,558 | $9.14 | $352.4K | 2,691,799 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-05-13 | 2022-05-16 | 17,744 | $9.14 | $162.2K | 319,415 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-05-12 | 2022-05-16 | 542,999 | $9.06 | $4.92M | 3,599,615 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-05-12 | 2022-05-16 | 457,001 | $9.06 | $4.14M | 2,653,241 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-06 | 2022-05-09 | 55,210 | $19.26 | $1.06M | 2,030,977 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-06 | 2022-05-09 | 40,659 | $19.26 | $783.1K | 1,507,023 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-06 | 2022-05-09 | 4,131 | $19.26 | $79.6K | 216,735 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-05 | 2022-05-09 | 70,439 | $19.60 | $1.38M | 1,466,364 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-05 | 2022-05-09 | 4,066 | $19.60 | $79.7K | 212,604 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-05-05 | 2022-05-09 | 75,495 | $19.60 | $1.48M | 1,975,767 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-04-01 | 2022-04-05 | 266,598 | $10.75 | $2.87M | 3,056,616 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | P Buy | 2022-04-01 | 2022-04-05 | 9,402 | $10.75 | $101.1K | 2,196,240 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2022-03-09 | 2022-03-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 14,323 | $40.70 | $582.9K | 1,395,925 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 20,085 | $40.70 | $817.5K | 1,900,272 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-01-27 | 2022-01-31 | 58,042 | $38.33 | $2.22M | 1,880,187 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-01-27 | 2022-01-31 | 37,859 | $38.33 | $1.45M | 1,381,602 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-01-24 | 2022-01-26 | 114,726 | $37.76 | $4.33M | 1,343,743 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2022-01-24 | 2022-01-26 | 158,041 | $37.76 | $5.97M | 1,822,145 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-01-19 | 2022-01-21 | 7,899 | $14.10 | $111.4K | 307,627 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-01-19 | 2022-01-21 | 412,264 | $14.10 | $5.81M | 2,315,625 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2022-01-19 | 2022-01-21 | 577,798 | $14.10 | $8.15M | 3,126,562 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-01-07 | 2022-01-10 | 14,806 | $12.00 | $177.7K | 185,388 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-01-07 | 2022-01-10 | 226,079 | $12.00 | $2.71M | 1,367,838 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-01-07 | 2022-01-10 | 255,500 | $12.00 | $3.07M | 1,734,960 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-01-06 | 2022-01-10 | 61,343 | $12.00 | $736.1K | 1,141,759 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2021-11-30 | 2021-12-02 | 35,268 | $9.39 | $331.2K | 471,350 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2021-11-30 | 2021-12-02 | 341,977 | $9.39 | $3.21M | 2,865,242 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2021-11-30 | 2021-12-02 | 362,430 | $9.39 | $3.40M | 3,755,093 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-10-08 | 2021-10-08 | 58,327 | $27.79 | $1.62M | 1,520,405 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-10-08 | 2021-10-08 | 8,929 | $27.79 | $248.1K | 232,747 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-10-08 | 2021-10-08 | 80,011 | $27.79 | $2.22M | 2,085,664 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-10-07 | 2021-10-08 | 384,914 | $27.53 | $10.60M | 1,578,732 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-10-07 | 2021-10-08 | 69,534 | $27.53 | $1.91M | 241,676 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-10-07 | 2021-10-08 | 530,999 | $27.53 | $14.62M | 2,165,675 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-21 | 2021-09-23 | 4,102 | $13.94 | $57.2K | 1,080,416 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-21 | 2021-09-23 | 6,341 | $13.94 | $88.4K | 1,479,460 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-21 | 2021-09-23 | 590 | $13.94 | $8.2K | 170,582 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-13 | 2021-09-15 | 158,511 | $16.49 | $2.61M | 1,076,314 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-13 | 2021-09-15 | 20,512 | $16.49 | $338.2K | 169,992 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-09-13 | 2021-09-15 | 213,246 | $16.49 | $3.52M | 1,473,119 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-07-06 | 2021-07-06 | 16,980 | $15.25 | $258.9K | 149,480 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-07-06 | 2021-07-06 | 146,116 | $15.25 | $2.23M | 1,259,873 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-07-06 | 2021-07-06 | 106,627 | $15.25 | $1.63M | 917,803 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-07-02 | 2021-07-07 | 150,805 | $20.75 | $3.13M | 311,210 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-07-02 | 2021-07-07 | 1,106,478 | $20.75 | $22.96M | 2,696,674 | SEC↗ |
| MRUS Merus N.V. | S Sale | 2021-07-02 | 2021-07-07 | 928,739 | $20.75 | $19.27M | 1,963,646 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | P Buy | 2021-07-01 | 2021-07-06 | 27,458 | $47.00 | $1.29M | 208,538 | SEC↗ |